Xerthra iPRF kit

PLATELET-RICH FIBRIN iPRF (injectable platelet-rich fibrin)XerthraTM iPRF kit – isolated autologous platelet-rich fibrin:
· a fibrin network entraps platelets and leukocytes

and enables growth factors and cytokines to be released over prolonged time.

Indications: improving regenerative properties of cells and tissues, i.e. in local meniscus degeneration.

Effectiveness of platelet rich plasma therapy depends on platelets amount contained in autologous plasma, because it has a direct impact on the growth factors amount in the product. Only concentration of platelet >1 million PLT/μl ensures the effectiveness of the therapy.
The highest concentration of platelets can only be obtained with specially dedicated devices. XerthraTM separa- tion device allows on average 1.5 million PLT/μl to be obtained, what gives 8 times higher concentration than in the peripheral blood.